Maravai Lifesciences Holdings (MRVI) Times Interest Earned (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Times Interest Earned of -$0.38 in Q1 2026, up 95.82% quarter-over-quarter from -$8.97 in Q4 2025, and up 94.82% on a YoY basis from -$0.19 in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Times Interest Earned (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Times Interest Earned history runs 7 years deep, the most recent figure standing at -$0.38 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 94.82% year-over-year to -$0.38; the TTM figure through Mar 2026 stood at -$6.48 (down 6.29% YoY), while the FY2025 annual figure was -$7.98, down 61.46% from the prior year.
- Times Interest Earned was -$0.38 for Q1 2026 at Maravai Lifesciences Holdings, up from -$8.97 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $62.83 in Q1 2022 to a low of -$12.15 in Q3 2024.
- Historically, Times Interest Earned has averaged $5.75 across 5 years, with a median of -$1.32 in 2023.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned soared 444.55% in 2022, then sank 911.03% in 2024.
- A 5-year view of Times Interest Earned shows it stood at $10.73 in 2022, then plunged by 104.33% to -$0.46 in 2023, then plunged by 620.98% to -$3.35 in 2024, then sank by 167.95% to -$8.97 in 2025, then surged by 95.82% to -$0.38 in 2026.
- The last three Times Interest Earned figures came in at -$0.38 (Q1 2026), -$8.97 (Q4 2025), and -$6.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -258.33 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 11.79 |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn | -0.38 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.38 |
| Dec 31, 2025 | -8.97 |
| Sep 30, 2025 | -6.00 |
| Jun 30, 2025 | -9.73 |
| Mar 31, 2025 | -7.25 |
| Dec 31, 2024 | -3.35 |
| Sep 30, 2024 | -12.15 |
| Jun 30, 2024 | -1.13 |
| Mar 31, 2024 | -1.74 |
| Dec 31, 2023 | -0.46 |
| Sep 30, 2023 | -1.32 |
| Jun 30, 2023 | -1.65 |
| Mar 31, 2023 | 0.21 |
| Dec 31, 2022 | 10.73 |
| Sep 30, 2022 | 37.28 |
| Jun 30, 2022 | 40.75 |
| Mar 31, 2022 | 62.83 |
| Dec 31, 2021 | 22.01 |
| Sep 30, 2021 | 20.22 |
| Jun 30, 2021 | 20.07 |